KEY FEATURES
| Full Name | Glucose Transporter 1 |
|---|---|
| Synonym | SLC2A1; SLC2-A1; GLUT; Solute Carrier Family 2 Member 1,Facilitated Glucose Transporter; Glucose transporter type 1, erythrocyte/brain; HepG2 glucose transporter |
| Assay Type | Sandwich |
| Reactivity | Human |
| Range | 0.31-20ng/mL |
| Sensitivity | 0.13ng/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Human GLUT1 in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human GLUT1. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human GLUT1 and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human GLUT1, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human GLUT1. You can calculate the concentration of Human GLUT1 in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human GLUT1 ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (ng/mL) | 1.1 | 1.81 | 7.23 | 1.21 | 1.97 | 6.72 |
| Standard deviation | 0.06 | 0.09 | 0.3 | 0.08 | 0.11 | 0.35 |
| CV(%) | 5.28 | 5.1 | 4.19 | 6.89 | 5.74 | 5.14 |
RECOVERY
The recovery of Human GLUT1 spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 92-108 | 99 |
| EDTA plasma (n=8) | 89-103 | 94 |
| Cell culture media (n=8) | 93-106 | 99 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human GLUT1 in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with GLUT1 ELISA Kits
| HIF1A ELISA Kit | publications with GLUT1 and HIF1A |
| MYC ELISA Kit | publications with GLUT1 and MYC |
| MAX ELISA Kit | publications with GLUT1 and MAX |
| ARNT ELISA Kit | publications with GLUT1 and ARNT |
| EPAS1 ELISA Kit | publications with GLUT1 and EPAS1 |
| UBC ELISA Kit | publications with GLUT1 and UBC |
| HDAC7 ELISA Kit | publications with GLUT1 and HDAC7 |
| CREBBP ELISA Kit | publications with GLUT1 and CREBBP |
| EP300 ELISA Kit | publications with GLUT1 and EP300 |
| GIPC1 ELISA Kit | publications with GLUT1 and GIPC1 |
Pathways associated with GLUT1 ELISA Kit
| Adipocytokine Signaling Pathway | Adipocytokine Signaling Pathway |
| Angiopoietin Like Protein 8 Regulatory Pathway | Angiopoietin Like Protein 8 Regulatory Pathway |
| Bile Secretion Pathway | Bile Secretion Pathway |
| Central Carbon Metabolism In Cancer Pathway | Central Carbon Metabolism In Cancer Pathway |
| Cori Cycle Pathway | Cori Cycle Pathway |
| Facilitative Na+-independent Glucose Transporters Pathway | Facilitative Na+-independent Glucose Transporters Pathway |
| Glucagon Signaling Pathway | Glucagon Signaling Pathway |
Diseases associated with GLUT1 ELISA Kit
| Nervous System Diseases | publications with GLUT1 and Nervous System Diseases |
| Seizures | publications with GLUT1 and Seizures |
| Glut1 Deficiency Syndrome | publications with GLUT1 and Glut1 Deficiency Syndrome |
| Metabolism, Inborn Errors | publications with GLUT1 and Metabolism, Inborn Errors |
| Liver Diseases | publications with GLUT1 and Liver Diseases |
| Kidney Diseases | publications with GLUT1 and Kidney Diseases |
| Breast Neoplasms | publications with GLUT1 and Breast Neoplasms |
| Necrosis | publications with GLUT1 and Necrosis |
| Liver Neoplasms | publications with GLUT1 and Liver Neoplasms |
| Diabetes Mellitus, Type 2 | publications with GLUT1 and Diabetes Mellitus, Type 2 |
Organs/Tissues associated with GLUT1 ELISA Kit
| Blood | publications with GLUT1 and Blood |
| Muscle | publications with GLUT1 and Muscle |
| Brain | publications with GLUT1 and Brain |
| Vascular | publications with GLUT1 and Vascular |
| Nerve | publications with GLUT1 and Nerve |
| Heart | publications with GLUT1 and Heart |
| Liver | publications with GLUT1 and Liver |
| Kidney | publications with GLUT1 and Kidney |
| Embryonic Tissue | publications with GLUT1 and Embryonic Tissue |
| Placenta | publications with GLUT1 and Placenta |